AINNOVI key facts
- Manufacturer of advanced medical imaging solutions aims to lead the refinement of visual imaging technologies for surgical applications.
- It has raised $13.7M; the latest was Later Stage VC ($13.7M) in Jan 2025.
- Notable investors include Tsing Stone Asset Management, Lotus Lake Ventures, Lingyi Capital, Zhongying Venture Capital, Sunland Fund — 6 tracked in total.
- Status: Privately Held (backing).
- ·Watch AINNOVI: the Monday email on marks, rounds and moves
AINNOVI funding rounds
No funding rounds for AINNOVI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
AINNOVI investors
6 investors are on record for AINNOVI, including Tsing Stone Asset Management, Lotus Lake Ventures, Lingyi Capital and Zhongying Venture Capital.
About AINNOVI
Manufacturer of advanced medical imaging solutions aims to lead the refinement of visual imaging technologies for surgical applications. The company's offerings feature ultra-high-definition 3D vision systems, intelligent human-computer interaction technologies, and computational imaging-based digital surgical solutions, helping hospitals and surgeons improve surgical precision, reduce operation time, and enhance teaching and patient recovery outcomes, enabling global adoption of next-generation medical imaging.
- Sector
- Healthcare
- HQ
- Jiaxing, China
- Founded
- 2020
- Website
- ainnovi.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
AINNOVI doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.